Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26468605 | 0.81 | — | — | |
| SCHEMBL26468597 | 0.79 | HSD17B10 (0.33) | HSD17B10 | |
| SCHEMBL26468614 | 0.71 | HSD17B10 (0.37) | HSD17B10LMNA | |
| SCHEMBL26468598 | 0.68 | — | — | |
| SCHEMBL12716898 | 0.59 | HSD17B10 (0.53) | HSD17B10LMNA | |
| SCHEMBL11564523 | 0.58 | HSD17B10 (0.40) | HSD17B10LMNA | |
| SCHEMBL10588859 | 0.56 | HSD17B10 (0.48) | HSD17B10LMNA | |
| SCHEMBL10192810 | 0.55 | HSD17B10 (0.52) | HSD17B10LMNA | |
| SCHEMBL7995598 | 0.55 | HSD17B10 (0.52) | HSD17B10LMNA | |
| SCHEMBL9396153 | 0.55 | ALDH1A1 (0.76) | HSD17B10LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230138884-A1 | HUMULUS SPECIES AS INDUSTRIAL CHEMICAL FEEDSTOCKS | P2 SCIENCE, INC. | 2023-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230138884-A1 | HUMULUS SPECIES AS INDUSTRIAL CHEMICAL FEEDSTOCKS | LSS, HSD17B14, HARS1 | HSD17B10 5/4885LMNA 3073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.